000 01841cam a2200277zu 4500
001 88835309
003 FRCYB88835309
005 20250107104134.0
006 m o d
007 cr un
008 250107s2016 fr | o|||||0|0|||eng d
020 _a9780128028261
035 _aFRCYB88835309
040 _aFR-PaCSA
_ben
_c
_erda
100 1 _aPeiman, Hematti
245 0 1 _aMesenchymal Stromal Cells
_bTranslational Pathways to Clinical Adoption
_c['Peiman, Hematti']
264 1 _bElsevier Science
_c2016
300 _a p.
336 _btxt
_2rdacontent
337 _bc
_2rdamdedia
338 _bc
_2rdacarrier
650 0 _a
700 0 _aPeiman, Hematti
856 4 0 _2Cyberlibris
_uhttps://international.scholarvox.com/netsen/book/88835309
_qtext/html
_a
520 _aMesenchymal Stromal Cells: Translational Pathways to Clinical Adoption provides the latest information on the necessary steps for successful production of stem cells for a clinical trial. Written by professionals with hands-on experience in bringing MSC therapies to the clinic, and building on the biology and mechanisms of action, this unique book covers the development and production of clinical-grade products that are suitable for use in humans. From design of a cell production facility, to obtaining regulatory approval and reimbursement issues, it is a useful guide for researchers and administrators across biomedical research.Provides methodologies for clinical MSC production, from designing a facility, to post-market approvalIncludes real-life examples of MSC production in academic centers and MSC production for biopharmaceutical clinical trialsOffers a unique perspective on the clinical aspects of MSC studies Presents the principles of clinical trials that can be applied to the production of various cell therapies
999 _c14814
_d14814